Heidi Nauwelaerts

Affiliations

Debiopharm International, Lausanne, Switzerland.

Réseau de co-auteurs

Jean Bourhis 2 collaborations

Yungan Tao 1 collaboration

Xu-Shan Sun 1 collaboration

Yoann Pointreau 1 collaboration

Christophe Le Tourneau 1 collaboration

Christian Sire 1 collaboration

Marie-Christine Kaminsky 1 collaboration

Alexandre Coutte 1 collaboration

Marc Alfonsi 1 collaboration

Benôit Calderon 1 collaboration

Pierre Boisselier 1 collaboration

Laurent Martin 1 collaboration

Jessica Miroir 1 collaboration

Jean-Francois Ramee 1 collaboration

Jean-Pierre Delord 1 collaboration

Florian Clatot 1 collaboration

Frederic Rolland 1 collaboration

Julie Villa 1 collaboration

Nicolas Magne 1 collaboration

Olgun Elicin 1 collaboration

Elisabeta Gherga 1 collaboration

France Nguyen 1 collaboration

Cédrik Lafond 1 collaboration

Guillaume Bera 1 collaboration

Valentin Calugaru 1 collaboration

Lionnel Geoffrois 1 collaboration

Bruno Chauffert 1 collaboration

Lars Damstrup 1 collaboration

Philippa Crompton 1 collaboration

Abdallah Ennaji 1 collaboration

Kathrin Gollmer 1 collaboration

Barbara Burtness 1 collaboration

Lisa F Licitra 1 collaboration

Christopher Nutting 1 collaboration

Jonathan D Schoenfeld 1 collaboration

Mokhtar Omar 1 collaboration

Florilene Bouisset 1 collaboration

Yulia Urfer 1 collaboration

Claudio Zanna 1 collaboration

Ezra Ew Cohen 1 collaboration

Heidi Nauwelaerts

Affiliations

Publications (2)

Extended follow-up of a phase 2 trial of xevinapant plus chemoradiotherapy in high-risk locally advanced squamous cell carcinoma of the head and neck: a randomised clinical trial.

Xevinapant or placebo plus chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck: TrilynX phase III study design.

Réseau de co-auteurs